Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort

Alzheimer Disease and Associated Disorders

Volumn 30, Issue 3, 2016, Pages 216-222

  Nimgaonkar, Vishwajit L ^a   Yolken, Robert H ^a   Wang, Tianxiu ^b   Chang, Chung Chou H ^b   McClain, Lora ^a   McDade, Eric ^b   Snitz, Beth E ^a   Ganguli, Mary ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; CMV; Cognition; Community; Epidemiology; Herpes virus; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

AGED; AGING; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEPTH PERCEPTION; EXECUTIVE FUNCTION; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; BLOOD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; IMMUNOLOGY; NEUROPSYCHOLOGICAL TEST; SIMPLEXVIRUS; STATISTICS AND NUMERICAL DATA; TOXOPLASMA; VIROLOGY;

AGED; AGING; ANTIBODIES, VIRAL; COGNITIVE DYSFUNCTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SIMPLEXVIRUS; TOXOPLASMA;

EID: 84951983629     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000133     Document Type: Article

References (40)

1. Dickerson FB, Boronow JJ, Stallings C, et al. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry. 2003;60:466-472.
2. Strandberg TE, Pitkala KH, Linnavuori KH, et al. Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke. 2003;34:2126-2131.
3. Shirts BH, Prasad KM, Pogue-Geile MF, et al. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res. 2008;106:268-274.
4. Yolken RH, Torrey EF, Lieberman JA, et al. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res. 2011;128:61-65.
5. Schretlen DJ, Vannorsdall TD, Winicki JM, et al. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophr Res. 2010;118:224-231.
6. Dickerson F, Stallings C, Origoni A, et al. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res. 2012;134:83-88.
7. Dickerson FB, Boronow JJ, Stallings C, et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry. 2004;55:588-593.
8. Watson AM, Prasad KM, Klei L, et al. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med. 2013;43:1023-1031.
9. Dickerson F, Stallings C, Sullens A, et al. Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain Behav Immun. 2008;22:1103-1107.
10. Prasad KM, Watson AM, et al. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull. 2012;38:1137-1148.
11. Tarter KD, Simanek AM, Dowd JB, et al. Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis. 2014;209:837-844.
12. Aiello AE, Haan MN, Pierce CM, et al. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci. 2008;63:610-618.
13. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006;43:1143-1151.
14. Schmutzhard E. Viral infections of the CNS with special emphasis on herpes simplex infections. J Neurol. 2001;248:469-477.
15. Lin WR, Wozniak MA, Wilcock GK, et al. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis. 2002;9:82-87.
16. Strandberg TE, Pitkala K, Eerola J, et al. Interaction of herpesviridae, APOE gene, and education in cognitive impairment. Neurobiol Aging. 2005;26:1001-1004.
17. Gajewski PD, Falkenstein M, Hengstler JG, et al. Toxoplasma gondii impairs memory in infected seniors. Brain Behav Immun. 2014;36:193-199.
18. Aiello AE, Haan M, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:1046-1054.
19. Barnes LL, Capuano AW, Aiello AE, et al. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis. 2014;211:230-237.
20. Carbone I, Lazzarotto T, Ianni M, et al. Herpes virus in Alzheimer's disease: relation to progression of the disease. Neurobiol Aging. 2014;35:122-129.
21. Ganguli M, Snitz B, Vander Bilt J, et al. How much do depressive symptoms affect cognition at the population level? The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) study. Int J Geriatr Psychiatry. 2009;24:1277-1284.
22. Ganguli M, Fu B, Snitz BE, et al. Vascular risk factors and cognitive decline in a population sample. Alzheimer Dis Assoc Disord. 2014;28:9-15.
23. Mungas D, Marshall SC, Weldon M, et al. Age and education correction of Mini-Mental State Examination for English and Spanish-speaking elderly. Neurology. 1996;46:700-706.
24. Ganguli M, Snitz BE, Lee CW, et al. Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team. Aging Ment Health. 2010;14:100-107.
25. Ganguli M, Fu B, Snitz BE, et al. Vascular risk factors and cognitive decline in a population sample. Alzheimer Dis Assoc Disord. 2014;28:9-15.
26. Wang K, Mahalingam G, Imai Y, et al. Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice. Virology. 2009;386:79-87.
27. Barker KR, Sarafino-Wani R, Khanom A, et al. Encephalitis in an immunocompetent man. J Clin Virol. 2014;59:1-3.
28. Markovitz AA, Simanek AM, Yolken RH, et al. Toxoplasma gondii and anxiety disorders in a community-based sample. Brain Behav Immun. 2015;43:192-197.
29. Dickerson F, Stallings C, Origoni A, et al. Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J Nerv Ment Dis. 2014;202:589-593.
30. Doggett JS, Nilsen A, Forquer I, et al. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc Natl Acad Sci USA. 2012;109:15936-15941.
31. Opsteegh M, Kortbeek TM, Havelaar AH, et al. Intervention strategies to reduce human Toxoplasma gondii disease burden. Clin Infect Dis. 2015;60:101-107.
32. Vescovini R, Biasini C, Fagnoni FF, et al. Massive load of functional effector CD4 + and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol. 2007;179:4283-4291.
33. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J Neurosci. 2010;30:16755-16762.
34. Wisniewski K, Jervis GA, Moretz RC, et al. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol. 1979;5:288-294.
35. Itzhaki RF. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Front Aging Neurosci. 2014;6:202.
36. Arfanakis K, Fleischman DA, Grisot G, et al. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One. 2013;8:e73107.
37. Fulop T, Larbi A, Pawelec G. Human T cell aging and the impact of persistent viral infections. Front Immunol. 2013;4:271.
38. Feinberg BB, Tan NS, Donovan PK, et al. Immunomodulation of cellular cytotoxicity to herpes simplex virus infection in pregnancy by inhibition of eicosanoid metabolism. J Reprod Immunol. 1993;23:109-118.
39. Kannan G, Pletnikov MV. Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective. Schizophr Bull. 2012;38:1155-1161.
40. Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among US adults. J Gerontol A Biol Sci Med Sci. 2009;64:272-279.